Summary: Researchers have identified the transcription factor MEIS2 as a key regulator of brain development, specifically in directing the formation of inhibitory projection neurons. Working together with DLX5, MEIS2 activates a set of enhancers and genes that steer precursor cells toward a projection neuron fate. A patient-associated MEIS2 variant fails to trigger these gene programs, linking the factor’s activity to neurodevelopmental disorders and intellectual disability.
This study clarifies how gene regulatory networks guide the emergence of neuron diversity in the embryonic brain. By showing how MEIS2 collaborates with other transcription factors to engage projection-neuron-specific enhancers, the work explains how small changes in gene regulation can reshape neuronal identity and contribute to disease.
Key Facts:
- MEIS2’s central role: MEIS2 promotes the development of GABAergic projection neurons by activating enhancer elements and genes required for their differentiation, working in concert with DLX5.
- Clinical relevance: A MEIS2 mutation found in patients with intellectual disability disrupts enhancer activation and projection neuron formation, highlighting a molecular link between altered gene regulation and neurodevelopmental impairment.
- Context-dependent gene control: MEIS2’s effect depends on partner proteins and local regulatory elements; in different tissues it engages distinct enhancers, explaining the varied symptoms associated with MEIS2 mutations.
Source: Max Planck Institute
Introduction
Brain development relies on tightly timed and spatially specific activation of gene programs. Neural progenitor cells give rise to many distinct neuron types by switching on precise combinations of genes, often through non-coding regulatory elements such as enhancers. Understanding how transcription factors target these enhancers is essential to explain how neuron diversity arises and how genetic variants perturb development.
A research team led by Christian Mayer at the Max Planck Institute for Biological Intelligence has focused on MEIS2, a transcription factor that plays a decisive role in determining whether certain inhibitory precursor cells develop into locally connected interneurons or long-range projection neurons. The study combined in vivo CRISPR perturbations, lineage tracing, and ChIP–sequencing to reveal MEIS2’s function and partners in the embryonic mouse brain.
Inhibitory cell lineages and neuronal diversity
Inhibitory GABAergic neurons comprise a diverse group that includes local interneurons within the cortex and long-range projection neurons that connect to subcortical targets. Both arise from the same germinal zones in the embryonic basal ganglia but adopt different identities through distinct gene expression programs. Tracking cell lineages with a barcoding approach, Mayer’s team traced how individual progenitors give rise to different inhibitory neuron types and identified MEIS2 as a factor that biases precursors toward projection neuron fates.
MEIS2 cooperates with DLX5 to activate projection programs
Mechanistically, MEIS2 does not act alone. The researchers found that MEIS2 must partner with the homeodomain factor DLX5 to bind and activate projection-neuron-specific enhancers. When MEIS2 is absent or nonfunctional, enhancer activation is reduced, fewer progenitors adopt the projection neuron identity, and more cells default to interneuron fates. This cooperation is cell-type specific: MEIS2 and DLX5 need to be co-expressed within the same cells and at the appropriate developmental time to drive the projection neuron program.
The study also notes an antagonistic influence from LHX6 in interneuron precursors: LHX6 can repress the MEIS2–DLX5-dependent activation of projection neuron enhancers, further shaping lineage choices within the germinal zone.
Disease link and functional consequences of MEIS2 variants
A MEIS2 variant previously identified in patients with intellectual disability and developmental delay was tested in the experimental system. This altered MEIS2 protein failed to induce the specific enhancer and gene activity required for projection neuron formation. Such failure provides a plausible molecular explanation for how mutations in a single transcription factor can lead to neurodevelopmental disorders by perturbing cell fate decisions during embryogenesis.
Enhancers, context, and pleiotropy
MEIS2’s diverse roles across tissues illustrate a general principle in developmental genetics: transcription factors achieve specificity through interactions with different partners and by targeting distinct sets of non-coding regulatory elements. Enhancers act as interpreters of combinatorial inputs; when MEIS2 teams up with DLX5 in the developing brain, one set of enhancers is activated to promote projection neuron identity. In other tissues MEIS2 pairs with different cofactors to engage alternative enhancers, explaining why mutations can produce a range of defects affecting digits, lung development, or cognitive function.
Large-scale sequencing studies have identified many risk genes for neurodevelopmental disorders. Future work that maps how these risk-gene products interact at enhancers will be essential to build a systems-level view of the molecular mechanisms that govern brain development and disease.
About this research
Author: Marius Bruer
Source: Max Planck Institute
Contact: Marius Bruer – Max Planck Institute
Image credit: Neuroscience News
Original Research: Spatial enhancer activation influences inhibitory neuron identity during mouse embryonic development — Christian Mayer et al., Nature Neuroscience. Open access.
Abstract (summary)
The mammalian telencephalon contains distinct GABAergic projection neuron and interneuron types that originate in the germinal zones of the embryonic basal ganglia. Using in vivo CRISPR perturbation, lineage tracing and ChIP–sequencing, this study shows that MEIS2 promotes projection neuron development by binding enhancers of projection-neuron-specific genes. MEIS2 requires DLX5 to direct activity toward appropriate binding sites, while LHX6 represses this activation in interneuron precursors. Mutations in Meis2 reduce enhancer activation and disrupt GABAergic differentiation, supporting a model in which differential transcription factor binding at cis-regulatory elements determines cell fate specification in the ganglionic eminence.